Yunyi Zhang
Overview
Explore the profile of Yunyi Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Zhang J, Chen J, Qi X, Zhang Z, Chen H, et al.
Foodborne Pathog Dis
. 2025 Feb;
PMID: 39992218
() is an important foodborne pathogen. In this study, 41 sporadic listeriosis cases were collected during 2016-2022, including 92.7% of invasive cases and 56.1% of pregnancy-associated cases. The age of...
2.
Xu S, Zhang L, Zhang Y, Peng Y, Zang Z, Cao Y, et al.
J Phys Chem Lett
. 2025 Feb;
16(8):1899-1908.
PMID: 39960027
Expediting the torpid kinetics of the acidic oxygen reduction reaction (ORR) is a crucial yet formidable challenge toward advancing proton exchange membrane fuel cells (PEMFCs) for commercialization. The cutting-edge Pd-based...
3.
Devaraja K, Avery J, Iyengar Y, Zhang Y, Climans S
Neurooncol Pract
. 2025 Feb;
12(1):143-152.
PMID: 39917753
Background: Primary central nervous system (CNS) tumors significantly affect individuals globally, with patients in Ontario, Canada, often bearing financial burdens for treatments such as oral chemotherapy due to insufficient coverage,...
4.
Mao Q, Tian X, Wang X, Xu H, Zhang Y, Kong Y
PLoS One
. 2025 Feb;
20(2):e0316767.
PMID: 39908338
Background: This research investigates the worldwide influence of cardiovascular diseases (CVD) associated with low intake of seafood omega-3 fatty acids, based on data from the 2021 Global Burden of Disease...
5.
Feng Y, Ge Q, Gao J, Wu Z, Zhang Y, Mao H, et al.
Molecules
. 2025 Jan;
30(2).
PMID: 39860255
Despite the widespread use of COVID-19 vaccines, there is still a global need to find effective therapeutics to deal with the variants of SARS-CoV-2. (MH) is a herbal medicine credited...
6.
Yu X, Zhang J, Zhang Y, Zhao X, Xu Z, Wang L, et al.
J Hepatobiliary Pancreat Sci
. 2025 Jan;
32(2):168-176.
PMID: 39801321
Background: Hepatolithiasis frequently presents with recurring cholangitis and complications. Oddi sphincter-preserved cholangioplasty with hepatico-subcutaneous stoma (OSPCHS), introduced in 1993, has shown favorable long-term results. Endoscopic sphincterotomy (EST) is commonly used,...
7.
Xue S, Bao W, Lyu J, Wang C, Zhang Y, Li H, et al.
Toxicon
. 2024 Dec;
254():108214.
PMID: 39674407
The structural similarity between aristolactams (ALs) and aristolochic acids (AAs) raises constant concerns about the safety of ALs-containing plants. Natural ALs are distributed more extensively than AAs, leading to a...
8.
Yuan Z, Fu M, Wang X, Wang M, Wei Y, Sun Y, et al.
Anal Methods
. 2024 Dec;
17(2):320-329.
PMID: 39628443
Nanozymes are nanomaterials with catalytic properties similar to enzymes and offer advantages over natural enzymes such as lower cost, ease of storage, and convenience for large-scale preparation. Thus, they have...
9.
Pan R, He Y, Melisandre W, Zhang Y, Su W, Feng J, et al.
Front Pharmacol
. 2024 Nov;
15:1437760.
PMID: 39539627
Background: Cardiovascular diseases (CVD) pose a significant threat to human health due to their high mortality and morbidity rates. Despite advances in treatments, the prevalence and impact of cardiovascular disease...
10.
Lin Z, Liu Z, Yang X, Pan Z, Feng Y, Zhang Y, et al.
Biomed Pharmacother
. 2024 Oct;
180:117558.
PMID: 39405915
The effective treatment regimens of triple-negative breast cancer (TNBC), a specific subtype of breast cancer (BC) with proneness to relapse and poor prognosis, are still lacking. Simeprevir (SIM), approved for...